Up-Regulation of Endothelial Nitric Oxide Synthase via Phosphatidylinositol 3-Kinase Pathway Contributes to Ischemic Tolerance in the CA1 Subfield of Gerbil Hippocampus
Open Access
- 1 March 2004
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 24 (3) , 271-279
- https://doi.org/10.1097/01.wcb.0000110539.96047.fc
Abstract
We here investigated endothelial nitric oxide synthase (eNOS) expression after 10 minutes of forebrain ischemia. Real-time polymerase chain reaction, immunoblots and immunohistochemical studies revealed up-regulation of eNOS expression in the hippocampal CA1 subfield of gerbil. Immunoreactivity of eNOS significantly increased in endothelium but neither in neurons nor astrocytes after 6 to 168 hours of reperfusion. An increased Akt activity preceded the postischemic eNOS up-regulation. Intracerebroventricular injection (i.c.v.) of wortmannin, an inhibitor of phosphatidylinositol 3-kinase (PI-3K), significantly inhibited the increases in both eNOS mRNA and its protein with concomitant inhibition of Akt activation. The significant increase in the eNOS expression was also evident following preconditioning 2-minute ischemia. Both eNOS up-regulation and acquisition of ischemic tolerance observed at 3 days after preconditioning ischemia were significantly inhibited by pretreatment with wortmannin. Administration (i.c.v.) of NG-nitro-L-arginine methyl ester, but not 7-nitroindazole, 30 minutes prior to lethal 10-minute ischemia, significantly abolished the acquired tolerance. Intraperitoneal injections of aminoguanidine at immediately after, 24, and 48 hours after preconditioning had no effects on the tolerance. These results suggest that eNOS expression is up-regulated in the endothelium via PI-3K pathways after transient forebrain ischemia, and that preconditioning-induced eNOS expression plays an important role in neuroprotection in the ischemic tolerance.Keywords
This publication has 43 references indexed in Scilit:
- NO produced by endothelial NO synthase is a mediator of delayed preconditioning-induced endothelial protectionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- Ischemic tolerance and endogenous neuroprotectionTrends in Neurosciences, 2003
- Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthaseAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2003
- Cardioprotective Function of Inducible Nitric Oxide Synthase and Role of Nitric Oxide in Myocardial Ischemia and Preconditioning: an Overview of a Decade of ResearchJournal of Molecular and Cellular Cardiology, 2001
- Up-regulation of Endothelial Nitric-oxide Synthase Promoter by the Phosphatidylinositol 3-Kinase γ/Janus Kinase 2/MEK-1-dependent PathwayJournal of Biological Chemistry, 2001
- Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic MiceStroke, 2000
- Cerebral Ischemia/Reperfusion Increases Endothelial Nitric Oxide Synthase Levels by An Indomethacin-Sensitive MechanismJournal of Cerebral Blood Flow & Metabolism, 1998
- Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity.Proceedings of the National Academy of Sciences, 1994
- L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat.Stroke, 1994
- Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats.Stroke, 1993